P636: REAL WORLD OUTCOME WITH IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA FROM THE GERMAN REALITY STUDY

• M. Welslau,
• R. Schlag,
• B. Heinrich,
• L. Vornholz,
• S. Buchholz,
• B. Marquard,
• S. Dörfel,
• G. Anke

Affiliations

M. Welslau

1 Oncology and Hematology, MVZ at Medical Clinic Aschaffenburg-Alzenau, Aschaffenburg

R. Schlag

2 Oncology and Hematology, Oncological Practice, Würzburg

B. Heinrich

3 Oncology and Hematology, Oncological Practice, Augsburg

L. Vornholz

4 Medical & Scientific Affairs, Janssen-Cilag GmbH, Neuss

S. Buchholz

4 Medical & Scientific Affairs, Janssen-Cilag GmbH, Neuss

B. Marquard

4 Medical & Scientific Affairs, Janssen-Cilag GmbH, Neuss

S. Dörfel

5 Oncology and Hematology, Onco Center Dresden, Dresden

G. Anke

6 Hematological and Oncological Diseases, MVZ Potsdam, Potsdam, Germany